Most Recent Articles about JAZZ
Is Jazz Pharmaceuticals (JAZZ) Stock Undervalued Right Now? http://www.zacks.com/stock/news/415565/is-jazz-pharmaceuticals-jazz-stock-undervalued-right-now?cid=CS-ZC-FT-415565 May 17, 2019 - Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Jazz Pharmaceuticals (JAZZ) Investor Presentation - Slideshow https://seekingalpha.com/article/4262638-jazz-pharmaceuticals-jazz-investor-presentation-slideshow?source=feed_sector_healthcare May 10, 2019 - The following slide deck was published by Jazz Pharmaceuticals plc in conjunction with this event.
3 Small Drug Stocks Poised to Beat Q1 Earnings Estimates http://www.zacks.com/stock/news/412663/3-small-drug-stocks-poised-to-beat-q1-earnings-estimates?cid=CS-ZC-FT-412663 May 10, 2019 - So far this earnings season, the going seems to be good for the medical sector. Let us take a glance at a few small drug companies, which are likely to beat on Q1 earnings.

Related Companies

Name Exchange Price Mkt Cap
PRGO Perrigo Company NYSE $72.57 $9.93B
BGNE BeiGene, Ltd. NASDAQ $159.91 $9.47B
ALNY Alnylam Pharmaceuticals, Inc. NASDAQ $93.43 $9.41B
NKTR Nektar Therapeutics NASDAQ $58.29 $10.05B
SRPT Sarepta Therapeutics, Inc. NASDAQ $152.52 $10.13B
Sector: Health Care > Industry: Major Pharmaceuticals